1,155 reports of this reaction
7.3% of all BENZOYL PEROXIDE reports
#4 most reported adverse reaction
ERYTHEMA is the #4 most commonly reported adverse reaction for BENZOYL PEROXIDE, manufactured by Alchemee, LLC. There are 1,155 FDA adverse event reports linking BENZOYL PEROXIDE to ERYTHEMA. This represents approximately 7.3% of all 15,861 adverse event reports for this drug.
Patients taking BENZOYL PEROXIDE who experience erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ERYTHEMA is moderately reported among BENZOYL PEROXIDE users, representing a notable but not dominant share of adverse events.
In addition to erythema, the following adverse reactions have been reported for BENZOYL PEROXIDE:
The following drugs have also been linked to erythema in FDA adverse event reports:
ERYTHEMA has been reported as an adverse event in 1,155 FDA reports for BENZOYL PEROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ERYTHEMA accounts for approximately 7.3% of all adverse event reports for BENZOYL PEROXIDE, making it a notable side effect.
If you experience erythema while taking BENZOYL PEROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.